Cartalax (20mg)

Cartalax Peptide Bioregulator Description

Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid. Its structure enables interaction with cellular mechanisms in cartilage (chondrocytes) and bone-regulating thyroid cells. The peptide may support joint health by promoting collagen production—a key structural protein in connective tissues—and reducing programmed cell death (apoptosis) in stressed cartilage cells. Its anti-inflammatory effects stem from inhibiting enzymes like matrix metalloproteinases that break down cartilage, while simultaneously curbing inflammatory signaling molecules. Cartalax also appears to influence calcium metabolism through thyroid C cells, potentially aiding bone density.

Cartalax Structure

Sequence: Ala-Glu-Asp (AED)

Molecular Formula: C₁₂H₁₉N₃O₈

Molecular Weight: 333.29 g/mol

PubChem CID: 87815447

Synonyms: 

• Ala-Glu-Asp
• alanyl-glutamyl-aspartic acid
• T-31 peptide
• H-Ala-Glu-Asp-OH

Research Areas:

• Skin Aging
• Renal Health
• Cartilage Function

Source: PubChem